Cardiac mortality, adequate power, and objective inclusion of the entire evidence are key to accurately define the long-term effect of revascularisation vs. medical therapy alone in stable coronary syndromes

Felicita Andreotti, Eliano P Navarese

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

This commentary refers to 'Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis', by E.P. Navarese et al., https:// doi.org/10.1093/eurheartj/ehab246; 'When a meta-analysis equals a single large-scale trial with meaningful follow-up', by E.P. Navarese et al., https://doi:10.1093/eurheartj/ ehab460; and the discussion pieces 'Cardiac death should be the primary endpoint for revascularisation trials and meta analyses', by H.D. White, https://doi.org/10.1093/ eurheartj/ehab676; `In the pool: dilution or drowning?'
Lingua originaleEnglish
pagine (da-a)4699-4700
Numero di pagine2
RivistaEuropean Heart Journal
Volume42
DOI
Stato di pubblicazionePubblicato - 2021

Keywords

  • revascularisation

Fingerprint

Entra nei temi di ricerca di 'Cardiac mortality, adequate power, and objective inclusion of the entire evidence are key to accurately define the long-term effect of revascularisation vs. medical therapy alone in stable coronary syndromes'. Insieme formano una fingerprint unica.

Cita questo